From the Journals

HCV, HBV, and HIV associated with autoimmune kidney diseases


 

FROM RHEUMATIC DISEASE CLINICS

Chronic viral infection can be associated with a variety of autoimmune kidney diseases, according to a review published in Rheumatic Disease Clinics.

London_England/Thinkstock

In particular, hepatitis C virus (HCV) infection can cause several kidney disorders. These include cryoglobulinemic glomerulonephritis, membranous nephropathy, fibrillary glomerulopathy, immunotactoid glomerulopathy, and IgA nephropathy, wrote Joshua D. Long and his colleagues at Massachusetts General Hospital, Boston.

Similarly, hepatitis B virus (HBV) infection was found to be associated with both membranous nephropathy and polyarteritis nodosa, and human immunodeficiency virus (HIV) infection can cause HIV-associated nephropathy and HIV-associated immune complex diseases, which affect the kidneys.

In their detailed review, the authors discussed the various causal mechanisms and clinical presentations of each of these various autoimmune kidney diseases caused by HCV, HBV, and HIV, along with current treatment modalities.

“Control of the kidney disease relies primarily on treatment of viremia with antiviral agents; however, immunosuppression also may be needed in severe cases,” said the reviewers. However, “more clinical trials are needed to determine first-line therapies for patients who develop autoimmune kidney diseases in the context of chronic viral infections and to define when adjunctive immunosuppressive therapy is warranted,” they concluded.

One of the authors reported grant support and acting as a consultant for various pharmaceutical companies.

mlesney@mdedge.com

SOURCE: Long JD et al. Rheum Dis Clin N Am 2018;44:675-98.

Recommended Reading

Witnessed overdose, HCV infection associated with greater opioid overdose risk
MDedge Internal Medicine
Model finds spontaneous HCV clearance higher than previous estimates
MDedge Internal Medicine
Outpatient costs soar for Medicare patients with chronic hepatitis B
MDedge Internal Medicine
Mutation in patients with chronic HCV raises risk of liver cancer
MDedge Internal Medicine
Transition to noninjected drug use lowers risk of HCV infection
MDedge Internal Medicine
Opiate use tied to hepatitis C risk in youth
MDedge Internal Medicine
DAAs top PEG/RBV for reducing HCV cardiovascular risk
MDedge Internal Medicine
Myeloperoxidase elevated in HCV-related liver cancer
MDedge Internal Medicine
HCV adapts to HIV coinfection
MDedge Internal Medicine
Synthetic HCV glycoproteins elicit narrow, but not widely effective antibodies
MDedge Internal Medicine